169 related articles for article (PubMed ID: 37973710)
1. Assessment of anthracycline-induced cardiotoxicity in childhood cancer survivors during long-term follow-up using strain analysis and intraventricular pressure gradient measurements.
Hosono Y; Takahashi K; Shigemitsu S; Akimoto S; Ifuku M; Yazaki K; Wakatsuki H; Yaguchi A; Tomita O; Fujimura J; Saito M; Yoneoka D; Shimizu T
Heart Vessels; 2024 Feb; 39(2):105-116. PubMed ID: 37973710
[TBL] [Abstract][Full Text] [Related]
2. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
[TBL] [Abstract][Full Text] [Related]
3. In-Depth Insight Into the Mechanisms of Cardiac Dysfunction in Patients With Childhood Cancer After Anthracycline Treatment Using Layer-Specific Strain Analysis.
Yazaki K; Takahashi K; Shigemitsu S; Yamada M; Iso T; Kobayashi M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Shimizu T
Circ J; 2018 Feb; 82(3):715-723. PubMed ID: 29187724
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
Kang Y; Xiao F; Chen H; Wang W; Shen L; Zhao H; Shen X; Chen F; He B
Arq Bras Cardiol; 2018 Mar; 110(3):219-228. PubMed ID: 29694546
[TBL] [Abstract][Full Text] [Related]
5. Left ventricle segmental function in childhood cancer survivors using speckle-tracking echocardiography.
Akam-Venkata J; Kadiu G; Galas J; Lipshultz SE; Aggarwal S
Cardiol Young; 2019 Dec; 29(12):1494-1500. PubMed ID: 31771663
[TBL] [Abstract][Full Text] [Related]
6. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of long-term cardiac side effects of anthracycline chemotherapy by conventional and non-conventional echocardiographic methods in childhood cancer survivors.
Yoldaş T; Yeşil Ş; Karademir S; Şahin G; Arman Örün U; Doğan V; Özgür S
Cardiol Young; 2019 Jul; 29(7):904-909. PubMed ID: 31218970
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic Assessment of Cardiac Function in Pediatric Survivors of Anthracycline-Treated Childhood Cancer.
Slieker MG; Fackoury C; Slorach C; Hui W; Friedberg MK; Fan CS; Manlhiot C; Dillenburg R; Kantor P; Mital S; Liu P; Nathan PC; Mertens L
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e008869. PubMed ID: 31826678
[TBL] [Abstract][Full Text] [Related]
9. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.
Vandecruys E; Mondelaers V; De Wolf D; Benoit Y; Suys B
J Cancer Surviv; 2012 Mar; 6(1):95-101. PubMed ID: 21630046
[TBL] [Abstract][Full Text] [Related]
10. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
[TBL] [Abstract][Full Text] [Related]
11. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine Growth Retardation is a Risk Factor for Anthracycline Toxicity.
Eroglu N; Yoldas T; Bilgin B; Yesil S; Fettah A; Sahin G
Pediatr Hematol Oncol; 2021 Aug; 38(5):497-503. PubMed ID: 33715575
[TBL] [Abstract][Full Text] [Related]
13. Two- and three-dimensional myocardial strain imaging in the interrogation of sex differences in cardiac mechanics of long-term survivors of childhood cancers.
Li VW; Liu AP; So EK; Ho KK; Yau JP; Cheuk DK; Cheung YF
Int J Cardiovasc Imaging; 2019 Jun; 35(6):999-1007. PubMed ID: 30848401
[TBL] [Abstract][Full Text] [Related]
14. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC
Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716
[TBL] [Abstract][Full Text] [Related]
15. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Myocardial Response to Exercise in Childhood Cancer Survivors Treated with Anthracyclines.
Cifra B; Chen CK; Fan CS; Slorach C; Manlhiot C; McCrindle BW; Dragulescu A; Redington AN; Friedberg MK; Nathan PC; Mertens L
J Am Soc Echocardiogr; 2018 Aug; 31(8):933-942. PubMed ID: 29615292
[TBL] [Abstract][Full Text] [Related]
17. Use of speckle tracking echocardiography to detect late anthracycline-induced cardiotoxicity in childhood cancer: A prospective controlled cross-sectional study.
Amedro P; Vincenti M; Abassi H; Lanot N; De La Villeon G; Guillaumont S; Gamon L; Mura T; Lopez-Perrin K; Haouy S; Sirvent A; Cazorla O; Vergely L; Lacampagne A; Avesani M; Sirvent N; Saumet L
Int J Cardiol; 2022 May; 354():75-83. PubMed ID: 35167907
[TBL] [Abstract][Full Text] [Related]
18. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
19. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer.
Dietz AC; Sivanandam S; Konety S; Kaufman CL; Gage RM; Kelly AS; Neglia JP; Mulrooney DA
J Cancer Surviv; 2014 Jun; 8(2):183-9. PubMed ID: 24317971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]